MedPath

南京鲸轮制药有限公司

Ownership
-
Established
2018-09-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Butoconazole Nitrate

Product Name
硝酸布康唑
Approval Number
国药准字H20110124
Approval Date
Mar 16, 2021
NMPA

Finasteride

Product Name
非那雄胺
Approval Number
国药准字H20041907
Approval Date
Jul 21, 2020
NMPA

Naftopidil

Product Name
萘哌地尔
Approval Number
国药准字H20020321
Approval Date
Jul 21, 2020
NMPA

Pyritinol Hydrochloride

Product Name
盐酸吡硫醇
Approval Number
国药准字H32020142
Approval Date
Jul 21, 2020
NMPA

Piracetam

Product Name
吡拉西坦
Approval Number
国药准字H32024073
Approval Date
Jul 21, 2020
NMPA

Lomefloxacin Hydrochloride

Approval Number
国药准字H19980160
Approval Date
Jul 21, 2020
NMPA

Chloramphenicol

Product Name
氯霉素
Approval Number
国药准字H32024066
Approval Date
Jul 21, 2020
NMPA

Ketoconazole

Product Name
酮康唑
Approval Number
国药准字H10900050
Approval Date
Jul 21, 2020
NMPA

Levamisole Hydrochloride

Product Name
盐酸左旋咪唑
Approval Number
国药准字H32024071
Approval Date
Jul 21, 2020
NMPA

Tolterodine Tartrate

Product Name
酒石酸托特罗定
Approval Number
国药准字H20000601
Approval Date
Jul 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.